SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Alfresa Holdings Corporation (ARHCF) trades at a trailing P/E of 0.1, forward P/E of 0.1. Trailing earnings yield is 1,250.00%, forward earnings yield 1,666.67%.
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.1); earnings yield beats bond yields (1,250.00%).
- Forward P/E 0.1 (down from trailing 0.1) — analysts expect earnings to grow, which would improve the valuation.
- Trailing Earnings Yield 1,250.00% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 1,666.67% as earnings recover.
Overall SharesGrow Score: 62/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ARHCF
Valuation Multiples
P/E (TTM)0.1
Forward P/E0.1
PEG RatioN/A
Forward PEG0.00
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$147.54
Forward EPS (Est.)$193.78
Book Value / Share$0.00
Revenue / Share$15,950.69
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1,250.00%
Forward Earnings Yield1,666.67%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$158.99 |
$2.58T |
$34.98B |
1.4% |
| 2017 |
$142.58 |
$2.55T |
$30.89B |
1.2% |
| 2018 |
$164.25 |
$2.6T |
$35.59B |
1.4% |
| 2019 |
$195.79 |
$2.64T |
$41.7B |
1.6% |
| 2020 |
$190.26 |
$2.7T |
$40.27B |
1.5% |
| 2021 |
$115.75 |
$2.6T |
$24.5B |
0.9% |
| 2022 |
$153.57 |
$2.59T |
$32.18B |
1.2% |
| 2023 |
$127.42 |
$2.7T |
$25.79B |
1% |
| 2024 |
$154.13 |
$2.86T |
$29.56B |
1% |
| 2025 |
$147.54 |
$2.96T |
$27.39B |
0.9% |
